4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-18-016993
Chief Financial Officer sold 3,000 shares at $28.12 ($84,360)
- Chief Financial Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
RAY DEBANJAN · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-04-02 | Exercise or conversion : show line 1 in the form | +3,000 | $1.26 | $3,780 | 7,741 | D |
| 2018-04-02 | Sale : show line 2 in the form | −3,000 | $28.12 | $84,360 | 4,741 | D |
| Open-market sales · 3,000 sh · avg $28.12 · $84,360 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-04-02 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −3,000 | 11,710 | D |
Loading xslF345X03/doc1.xml…